市場調査レポート
商品コード
1422068
創傷治療市場:製品・用途・購入モード・流通チャネル・エンドユーザー・地域別、機会、予測、2017年~2031年Wound Care Market Assessment, By Product By Applications, Mode of Purchase, Distribution Channel, By End-user, By Region, Opportunities and Forecast, 2017-2031F |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
創傷治療市場:製品・用途・購入モード・流通チャネル・エンドユーザー・地域別、機会、予測、2017年~2031年 |
出版日: 2024年02月07日
発行: Market Xcel - Markets and Data
ページ情報: 英文 223 Pages
納期: 3~5営業日
|
世界の創傷治療の市場規模は、2023年の256億7,000万米ドルから、予測期間中は4.42%のCAGRで推移し、2031年には362億8,000万米ドルに達すると予測されています。
世界の創傷治療市場の成長を後押しする要素は数多くあり、人口動態の高齢化、糖尿病性潰瘍などの慢性創傷の増加、創傷治療技術の進歩、先進的な創傷治療に対する認知度の向上、回復の促進や入院期間の短縮への関心の高まりなどが挙げられます。さらに、ライフスタイルの変化、外科手術の普及、新興国における高度な創傷治療ソリューションへのニーズの高まりも、市場成長に大きな影響を与えています。
糖尿病性潰瘍の増加は市場拡大を促進する重要な要因となっています。糖尿病性潰瘍は、血流の低下や神経損傷により糖尿病の合併症として生じることが多く、その結果、傷の治りが遅くなります。糖尿病患者の増加に伴い、糖尿病性潰瘍の発生は大幅に増加しており、効果的な管理のための高度な創傷治療ソリューションが必要とされています。先進的なドレッシング材、治癒促進療法、糖尿病性潰瘍の管理強化に特化した新技術など、特殊な治療法の開発・導入が重視されるようになっています。カスタマイズされた創傷治療ソリューションに対する要求の高まりは、世界の創傷治療市場の拡大と多様化に大きく寄与しています。
世界の創傷治療市場では近年著しい技術的進歩を遂げています。これらの技術革新は創傷管理に革命をもたらし、患者の転帰とヘルスケアの効率を向上させています。ハイドロゲル、発泡体、フィルムなどの高度な創傷被覆材は、より優れた水分管理、感染管理、迅速な治癒を提供します。スマート素材やセンサーを創傷治療製品に組み込むことで、創傷の状態をリアルタイムでモニタリングでき、タイムリーな介入が可能になります。
当レポートでは、世界の創傷治療の市場を調査し、市場の定義と概要、市場規模の推移・予測、各種区分・地域別の詳細分析、産業構造、市場成長への影響因子の分析、ケーススタディ、競合情勢、主要企業のプロファイルなどをまとめています。
Global Wound Care Market size was valued at USD 25.67 billion in 2023, expected to reach USD 36.28 billion in 2031, with a CAGR of 4.42% for the forecast period between 2024 and 2031F. Numerous elements propel the expansion of global wound care market, encompassing an aging demographic, escalating instances of chronic wounds like diabetic ulcers, advancements in wound care technology, heightened recognition of progressive wound therapies, and an increasing focus on expediting recovery and minimizing hospital durations. Moreover, shifts in lifestyle, the prevalence of surgical interventions, and the rising need for advanced wound care solutions in developing nations exert substantial influence on the growth trajectory of the global wound care market.
The global wound care market undergoes robust growth due to diverse factors. Initially, the aging population globally plays a significant role in this expansion. As people age, their susceptibility to chronic conditions rises, leading to an upsurge in chronic wounds like diabetic ulcers. The growing prevalence drives the need for innovative wound care solutions in the global wound care market. Concurrently, continuous progress in wound care technology holds immense importance. Innovations in materials, treatments, and approaches elevate the effectiveness and efficiency of wound care products. Furthermore, increased awareness and recognition of advanced wound therapies steer patient and healthcare provider preferences toward these modern solutions.
Strategies aimed at hastening recovery and reducing hospital stays drive the growth in global wound care market. Healthcare approaches increasingly focus on expediting healing processes, lessening the strain on healthcare facilities and cutting costs for patients and providers alike. Lifestyle changes significantly impact the market, often contributing to a rise in wounds that necessitate advanced wound care solutions. Moreover, the global increase in surgical procedures further escalates the demand for these products. Lastly, emerging economies experiencing heightened requirements for advanced wound care solutions due to evolving healthcare structures and augmented healthcare expenditures substantially contribute to expanding the global wound care market. This amalgamation of factors outlines a sturdy growth path for the global wound care market.
The increase in diabetic ulcer cases acts as a crucial catalyst driving the expansion of the global wound care market. Diabetic ulcers, frequently arising as a complication of diabetes due to diminished blood flow and nerve damage, result in slow-healing wounds. With diabetes becoming more prevalent worldwide, the occurrence of diabetic ulcers has risen substantially, necessitating advanced wound care solutions for effective management. The surge in diabetic ulcer prevalence fuels the demand for innovative wound care products and therapies tailored to address these complex wounds. Consequently, there is a heightened emphasis on creating and implementing specialized treatments, including advanced dressings, healing-accelerating therapies, and novel technologies crafted specifically to enhance the management of diabetic ulcers. Increased requirement for customized wound care solutions significantly contribute to both the expansion and diversification of the global wound care market.
Global wound care market has witnessed significant technological advancements in recent years. These innovations have revolutionized wound management, improving patient outcomes and healthcare efficiency. Advanced wound dressings, such as hydrogels, foams, and films, offer better moisture management, infection control, and faster healing. The integration of smart materials and sensors into wound care products allows for real-time monitoring of wound status, facilitating timely interventions.
For instance, in January 2023, Convatec Group PLC introduced ConvaFoam, an innovative foam dressing designed to cater to the needs of patients and healthcare providers in the realms of skin protection and wound management. Improved silicone technology for better adhesion2, better absorbency fluid handling, a 7-day wear period, a patterned film design that can facilitate exudate monitoring, and a superabsorbent layer are all features of the ConvaFoam family of dressings. Additionally, ConvaFoam is scalable, making it easier to apply to hard-to-dress regions.
The increased requirement for surgical wound care significantly drives the expansion of the global wound care market. The heightened need primarily arises from the growing frequency of worldwide surgical procedures. As surgeries become more prevalent across diverse medical fields, there arises an inherent necessity for efficient post-surgical wound care solutions. Consequently, the market witnesses a heightened demand for advanced wound care products and tailored therapies to address the varied demands of managing surgical wounds. The increased need stimulates innovation within the wound care sector, leading to the creation of specialized dressings, healing methodologies, and technologies are specifically designed to enhance the recovery and healing processes for surgical wounds, ultimately, driving substantial growth in the global wound care market.
For instance, Sylke Inc. introduced SYLKE, the first dressing composed entirely of hypoallergenic silk fibroin, in October 2023. SYLKE is intended to improve wound healing following surgery and to lower the risk of complications and infections that could result in unfavorable scarring. By eradicating skin damage caused by medical adhesives that result in consequences like infections and unfavorable scarring, SYLKE hopes to transform surgical wound care.
The increasing uptake of negative pressure wound therapy (NPWT) significantly propels the global wound care market's expansion. NPWT, entailing the application of controlled negative pressure to wounds, accelerates healing by eliminating excess fluids and promoting tissue growth. Its established effectiveness in managing intricate wounds such as diabetic ulcers and chronic injuries prompts healthcare providers to adopt NPWT more frequently. The escalating usage fosters market expansion, spurring heightened demand for NPWT devices, accessories, and related consumables. Consequently, the surge fuel advancements and research in this specialized field of wound care, ultimately steering the overall growth of the global wound care market. For example, Medela announced in August 2023 that it would be adding the new Invia integrated dressing, which is recommended for all types of wounds, to its range of negative pressure wound therapy (NPWT) products. All wound types, including closed surgical incisions, are designed to be treated with the new sterile dressing. It can be used at home or in a hospital setting for up to seven days.
The wound care management market was significantly affected by the COVID-19 outbreak, leading to widespread repercussions in the global economy and the provision of general hospital care to uninfected patients. For instance, a study published in September 2021 by the National Center for Biotechnology Information (NCBI) revealed that a notable portion of patients with chronic wounds postponed both preventive and urgent wound care during the pandemic. Moreover, there was a heightened emphasis on wound care during the pandemic to reduce hospitalizations and surgeries and prevent severe wound complications. An article by UpToDate Inc. in June 2022 pointed out that the COVID-19 pandemic, prompting a shift in the delivery of wound care, an essential medical service. Consequently, reduced availability of wound care management services during the pandemic had an adverse impact on the market.
Prominent firms in the wound care industry have been strategically acquiring businesses to broaden their range of products and strengthen their position in the global wound care market. For instance, a leading supplier of advanced wound care products, Systagenix Wound Management Ltd. was acquired by Acelity L.P. Inc. in April 2023. The USD 485 million transaction is anticipated to broaden Acelity's product line for wound treatment. B. Braun Medical Inc. announced the acquisition of the Epitech Group, a major manufacturer of wound care products, in March 2023. The acquisition is expected to increase B. Braun's footprint in the wound care sector and broaden its product line. Smith & Nephew acquired Osiris Therapeutics, Inc. in December 2022, a premier biotechnology business focusing on regenerative medicine products for wound treatment. The acquisition of USD 660 million will strengthen the footprints of Smith & Nephew in the global wound care market.
All segments will be provided for all regions and countries covered:
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.